B

BIOGEN INC.

BIIB NASDAQ Healthcare · Drug Manufacturers - General www.biogen.com
$216.78
Mkt Cap 32.03B
—
/100 Overall
Calculating score…
Running full analysis
Ready to value this company?
Run a full DCF model with Monte Carlo simulation.
Run DCF Valuation →
📊 Key Metrics
Loading full analysis…
REVENUE TTM
$9.86B
-6% CAGR
FCF TTM
$2.62B
26.6% margin
P/E RATIO
23.3x
—
P/FCF
12.2x
—
Running full 6-factor analysis…